Capecitabine-induced coronary vasospasm.
Goldsmith
Yuliya B
YB
Department of Cardiology, Memorial Sloan-Kettering Cancer Center, New York, NY, USA.
Roistacher
Nancy
N
Baum
Michael S
MS
D000328:Adult; D000964:Antimetabolites, Antineoplastic / Q000009:adverse effects*; D001943:Breast Neoplasms / Q000188:drug therapy* / Q000601:surgery; D000069287:Capecitabine; D018270:Carcinoma, Ductal, Breast / Q000188:drug therapy* / Q000601:surgery; D003329:Coronary Vasospasm / Q000139:chemically induced* / Q000000981:diagnostic imaging; D003841:Deoxycytidine / Q000009:adverse effects / Q000031:analogs & derivatives*; D004452:Echocardiography; D004562:Electrocardiography; D005260:Female; D005472:Fluorouracil / Q000009:adverse effects / Q000031:analogs & derivatives*; D006801:Humans; D009364:Neoplasm Recurrence, Local
D000964:Antimetabolites, Antineoplastic; D003841:Deoxycytidine; D000069287:Capecitabine; D005472:Fluorouracil